Literature DB >> 31003210

Neurological and neuropsychological outcome after resection of craniopharyngiomas.

Henrik Giese, Benjamin Haenig, Anna Haenig, Andreas Unterberg, Klaus Zweckberger.   

Abstract

OBJECTIVE: Craniopharyngiomas are rare and benign tumors of the sellar and/or parasellar region. Primary treatment involves resection followed by adjuvant radiotherapy. While the grade of resection was frequently analyzed following surgery, the neurological outcome and especially neuropsychological deficits and quality of life have been neglected for many decades. Therefore, the authors retrospectively analyzed their patient series and prospectively assessed neuropsychological outcome and quality of life following resection of craniopharyngiomas in adults.
METHODS: In total, 71 patients (39 men and 32 women) with a mean age of 49 years were enrolled in the retrospective analysis. In addition, 36 of the 71 patients were included in the prospective arm of the study and underwent neurological and neuropsychological testing as well as quality of life (36-Item Short-Form Health Survey; SF-36) assessment. Factors influencing outcome were identified and correlations calculated.
RESULTS: Resection was performed mostly using a pterional (41.6%, 47/113 surgical procedures) or bifrontal translamina terminalis (30.1%, 34/113 surgical procedures) approach. Following surgery, visual acuity was significantly improved (> 0.2 diopters) in 32.4% (23/71) of patients, or remained stable in 45.1% (32/71) of patients. During long-term follow up, 80.3% (57/71) of patients developed pituitary insufficiency, particularly involving the corticotropic and thyrotrophic axes. In total, 75% (27/36) of patients showed neuropsychological deviations in at least 1 test item. In particular, attentiveness, cognitive speed, and short-term memory were affected. Referring to the SF-36 score, quality of life was affected in both the mental and physical score in 19.4% (7/36) and 33.3% (12/36), respectively. The risk factors that were identified were a tumor volume larger than 9 cm3, tumor extension toward/into the third ventricle or the brainstem, and resection using a bifrontal translamina terminalis or left-sided approach.
CONCLUSIONS: This study demonstrated that resection of craniopharyngiomas is frequently associated with postoperative neuropsychological deficits and hence an impaired quality of life. In addition to tumor size and extension toward/into the third ventricle or the brainstem, selection of the surgical approach may play a crucial role in the patient's neuropsychological outcome and quality of life.

Entities:  

Keywords:  craniopharyngioma; grade of resection; neurological outcome; neuropsychological outcome; oncology

Year:  2019        PMID: 31003210     DOI: 10.3171/2018.10.JNS181557

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Authors:  Shingo Fujio; Tareq A Juratli; Daniel P Cahill; Fred G Barker; Priscilla K Brastianos
Journal:  Neurosurgery       Date:  2019-11-01       Impact factor: 4.654

2.  Craniopharyngioma and the Third Ventricle: This Inescapable Topographical Relationship.

Authors:  José María Pascual; Ruth Prieto
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

3.  Fatal Fungal Aneurysm Rupture Due to Aspergillosis after Craniopharyngioma Removal via Endoscopic Endonasal Surgery: Case Report and Comparison with Seven Reported Patients.

Authors:  Mari Kusumi; Hidehiro Oka; Hidehito Kimura; Hitoshi Yamazaki; Koji Kondo; Toshihiro Kumabe
Journal:  NMC Case Rep J       Date:  2022-07-19

4.  Costs and Its Determinants in Pituitary Tumour Surgery.

Authors:  Alies J Dekkers; Friso de Vries; Amir H Zamanipoor Najafabadi; Emmy M van der Hoeven; Marco J T Verstegen; Alberto M Pereira; Wouter R van Furth; Nienke R Biermasz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

5.  Craniopharyngiomas, including Recurrent Cases, Lack TERT Promoter Hotspot Mutations.

Authors:  Shingo Fujio; Tareq A Juratli; Tomoko Takajo; Kazunori Arita; Yushi Nagano; Koji Yoshimoto; Naema Nayyar; William T Curry; Maria Martinez-Lage; Daniel P Cahill; Fred G Barker; Priscilla K Brastianos
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-05-08       Impact factor: 1.742

6.  Development and Validation of Predicting Nomograms for Craniopharyngioma: A Retrospective, Multiple-Center, Cohort Study.

Authors:  Dingkang Xu; Qingjie Wei; Zhe Li; Yan Hu; Peizhu Hu; Shengqi Zhao; Dengpan Song; Shixiong Lei; Mingchu Zhang; Qiang Gao; Longxiao Zhang; Fangbo Lin; Yuchao Zuo; Xianzhi Liu; Mengzhao Feng; Chunxiao Ma; Fuyou Guo
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

Review 7.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.